Results 141 to 150 of about 21,457 (218)

Development and Validation of an Interpretable Machine Learning Model for Predicting Thrombocythemia Risk During Third Generation Cephalosporin Therapy. [PDF]

J Blood Med
Du K, Wang M, Yu P.
europepmc   +1 more source

Acute STEMI in a young adult without conventional risk factors: a case report of JAK2-positive essential thrombocythemia. [PDF]

Eur Heart J Case Rep
Chen DM, Shin ED, Lee E, Xu L, Enders CL.   +4 more
europepmc   +1 more source

Delayed Splenial Artery Pseudoaneurysm After Angiographically Negative Intracerebral Hemorrhage: A Case Report. [PDF]

Cureus
Ueda K, Mitsutake T, Kadooka K, Tanaka M.   +3 more
europepmc   +1 more source

DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]

Ann Hematol
Arafat AMA, Ghaffar HAA, Khallaf AM, Younes SAM, Morad MA, Mahgoub SMA.   +5 more
europepmc   +1 more source

Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms. [PDF]

Int J Endocrinol
Aydin MS, Dagdas S, Pepeler MS, Korkmaz G, Alper A, Açıkgöz E, Bektas TN, Pamukçuoğlu M, Ceran F, Ozet G.   +9 more
europepmc   +1 more source

4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]

Thromb J
Zhang X, Guo X.
europepmc   +1 more source

Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms. [PDF]

Ann Hematol
Abu-Zeinah G, Hobbs G, Reeves BN, Yacoub A, Scandura JM.   +4 more
europepmc   +1 more source

Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026. [PDF]

Ther Adv Hematol
Al-Zubaidi N, Makris K, Sriskandarajah P.   +2 more
europepmc   +1 more source

Application of NanoString Technologies in Chronic Myeloid Leukemia, Essential Thrombocythemia, Primary Myelofibrosis, and Polycythemia Vera: A Pilot Study. [PDF]

Diagnostics (Basel)
Bae JH, Bae KJ, Cho CH.
europepmc   +1 more source

Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97). [PDF]

Front Oncol
Felser S, Koeppel M, Kuehl R, le Coutre P, Al-Ali HK, Schulze S, Muegge LO, Bormann J, Geissler J, Dadgar A, Junghanss C, Ulbricht S.   +11 more
europepmc   +1 more source